Tryptoline
| Tryptoline | |
|---|---|
|
1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole |
|
|
Other names
Noreleagnine |
|
| Identifiers | |
| CAS number | 16502-01-5 |
| PubChem | 107838 |
| ChemSpider | 96979 |
| ChEMBL | CHEMBL269236 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C11H12N2 |
| Molar mass | 172.226 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
Tryptoline, also known as tetrahydro-β-carboline and tetrahydronorharmane, is a natural organic derivative of beta-carboline. It is an alkaloid chemically related to tryptamines. Derivatives of tryptoline have a variety of pharmacological properties and are known collectively as tryptolines.
[edit] Pharmacology
|
|
This article needs attention from an expert on the subject. See the talk page for details. WikiProject Pharmacology or the Pharmacology Portal may be able to help recruit an expert. (June 2009) |
Many tryptolines are competitive selective inhibitors of the enzyme monoamine oxidase type A (MAO-A). 5-Hydroxytryptoline and 5-methoxytryptoline are the most active monoamine oxidase inhibitors (MAOIs) with IC50s of 0.5 μM and 1.5 μM respectively, using 5-hydroxytryptamine (serotonin) as substrate.
Tryptolines are also potent reuptake inhibitors of serotonin and epinephrine, with a significantly greater selectivity for serotonin. Comparison of the inhibition kinetics of tetrahydro-β-carbolines for serotonin and epinephrine reuptake to that of the platelet aggregation response to these amines has shown that 5-hydroxymethtryptoline, methtryptoline, and tryptoline are poor inhibitors of reuptake. In all respects 5-hydroxytryptoline and 5-methoxytryptoline showed greater pharmacological activity than the tryptoline and methtryptoline.
Although the in vivo formation of tryptolines has been a matter of controversy, they have profound pharmacological activity.
[edit] See also
[edit] References
- H. Rommelspacher, H. Kauffmann, C. Heyck Cohnitz and H. Coper (1977). "Pharmacological properties of tetrahydronorharmane (Tryptoline)". Journal Naunyn-Schmiedeberg's Archives of Pharmacology 298 (2): 83–91. doi:10.1007/BF00508615. http://www.springerlink.com/content/g264075045877742/.